NLRX1
Basic information
Region (hg38): 11:119166568-119184016
Links
Phenotypes
GenCC
Source:
ClinVar
This is a list of variants' phenotypes submitted to
Variants pathogenicity by type
Statistics on ClinVar variants can assist in determining whether a specific variant type in the NLRX1 gene is commonly pathogenic or not.
In the table, we include only reliable ClinVar variants with their consequences to MANE Select, Mane Plus Clinical transcripts, or transcripts with TSL equals 1. Click the count to view the source variants.
Warning: slight differences between displayed counts and the number of variants in ClinVar may occur, primarily due to (1) the application of a different transcript and/or consequence by our variant effect predictor or (2) differences in clinical significance: we classify Benign/Likely benign variants as Likely benign and Pathogenic/Likely pathogenic variants as Likely pathogenic.
Variant type | Pathogenic | Likely pathogenic | VUS | Likely benign | Benign | Sum |
---|---|---|---|---|---|---|
synonymous | 2 | |||||
missense | 67 | 71 | ||||
nonsense | 0 | |||||
start loss | 0 | |||||
frameshift | 0 | |||||
inframe indel | 0 | |||||
splice donor/acceptor (+/-2bp) | 0 | |||||
splice region | 0 | |||||
non coding | 0 | |||||
Total | 0 | 0 | 67 | 3 | 3 |
Variants in NLRX1
This is a list of pathogenic ClinVar variants found in the NLRX1 region.
You can filter this list by clicking the number of variants in the Variants pathogenicity by type table.
Position | Type | Phenotype | Significance | ClinVar |
---|---|---|---|---|
11-119168034-G-A | not provided (-) | |||
11-119168321-G-A | not provided (-) | |||
11-119168342-T-C | not provided (-) | |||
11-119168442-C-T | not provided (-) | |||
11-119168581-C-T | not provided (-) | |||
11-119168682-T-C | not provided (-) | |||
11-119171357-A-G | not provided (-) | |||
11-119171367-G-C | not provided (-) | |||
11-119171428-A-G | not specified | Uncertain significance (Oct 05, 2023) | ||
11-119171716-G-C | not provided (-) | |||
11-119171728-G-A | not provided (-) | |||
11-119172362-G-A | Benign (May 30, 2018) | |||
11-119172416-G-A | not specified | Uncertain significance (Oct 26, 2021) | ||
11-119172685-G-A | not provided (-) | |||
11-119172954-G-T | not specified | Uncertain significance (Dec 18, 2023) | ||
11-119173359-T-C | not provided (-) | |||
11-119173368-C-T | not provided (-) | |||
11-119173387-G-A | not provided (-) | |||
11-119173388-T-C | not provided (-) | |||
11-119173500-G-T | not specified | Uncertain significance (Jul 14, 2021) | ||
11-119173524-G-A | not specified | Uncertain significance (Jun 21, 2022) | ||
11-119173541-C-T | not specified | Uncertain significance (May 03, 2023) | ||
11-119173557-C-G | not specified | Uncertain significance (Mar 07, 2024) | ||
11-119173580-G-A | not specified | Uncertain significance (Apr 22, 2024) | ||
11-119173596-G-A | not specified | Uncertain significance (Apr 15, 2024) |
GnomAD
Source:
Gene | Type | Bio Type | Transcript | Coding Exons | Length |
---|---|---|---|---|---|
NLRX1 | protein_coding | protein_coding | ENST00000409109 | 9 | 17449 |
pLI Probability LOF Intolerant | pRec Probability LOF Recessive | Individuals with no LOFs | Individuals with Homozygous LOFs | Individuals with Heterozygous LOFs | Defined | p |
---|---|---|---|---|---|---|
7.73e-31 | 0.00000324 | 125337 | 1 | 410 | 125748 | 0.00164 |
Z-Score | Observed | Expected | Observed/Expected | Mutation Rate | Total Possible in Transcript | |
---|---|---|---|---|---|---|
Missense | 0.134 | 604 | 613 | 0.985 | 0.0000427 | 6192 |
Missense in Polyphen | 189 | 204.79 | 0.92289 | 2345 | ||
Synonymous | 0.429 | 251 | 260 | 0.966 | 0.0000163 | 2210 |
Loss of Function | -1.07 | 42 | 35.2 | 1.19 | 0.00000219 | 346 |
LoF frequencies by population
Ethnicity | Sum of pLOFs | p |
---|---|---|
African & African-American | 0.00481 | 0.00475 |
Ashkenazi Jewish | 0.00 | 0.00 |
East Asian | 0.000382 | 0.000381 |
Finnish | 0.00130 | 0.00129 |
European (Non-Finnish) | 0.00118 | 0.00116 |
Middle Eastern | 0.000382 | 0.000381 |
South Asian | 0.00435 | 0.00432 |
Other | 0.000327 | 0.000326 |
dbNSFP
Source:
- Function
- FUNCTION: Participates in antiviral signaling. Acts as a negative regulator of MAVS-mediated antiviral responses, through the inhibition of the virus-induced RLH (RIG-like helicase)-MAVS interaction (PubMed:18200010). Instead, promotes autophagy by interacting with TUFM and subsequently recruiting the autophagy- related proteins ATG5 and ATG12 (PubMed:22749352). Regulates also MAVS-dependent NLRP3 inflammasome activation to attenuate apoptosis (PubMed:27393910). Has no inhibitory function on NF- kappa-B signaling pathway, but enhances NF-kappa-B and JUN N- terminal kinase dependent signaling through the production of reactive oxygen species (PubMed:18219313). {ECO:0000269|PubMed:18200010, ECO:0000269|PubMed:18219313, ECO:0000269|PubMed:22749352, ECO:0000269|PubMed:27393910}.;
- Pathway
- Influenza A - Homo sapiens (human);NOD-like receptor signaling pathway - Homo sapiens (human);RIG-I-like receptor signaling pathway - Homo sapiens (human);RIG-I-like Receptor Signaling;DDX58/IFIH1-mediated induction of interferon-alpha/beta;Innate Immune System;Immune System;Negative regulators of DDX58/IFIH1 signaling
(Consensus)
Recessive Scores
- pRec
- 0.134
Intolerance Scores
- loftool
- 0.946
- rvis_EVS
- 0.19
- rvis_percentile_EVS
- 66.58
Haploinsufficiency Scores
- pHI
- 0.0945
- hipred
- N
- hipred_score
- 0.197
- ghis
- 0.467
Essentials
- essential_gene_CRISPR
- N
- essential_gene_CRISPR2
- N
- essential_gene_gene_trap
- N
- gene_indispensability_pred
- E
- gene_indispensability_score
- 0.564
Gene Damage Prediction
All | Recessive | Dominant | |
---|---|---|---|
Mendelian | Medium | Medium | Medium |
Primary Immunodeficiency | Medium | Medium | Medium |
Cancer | Medium | Medium | Medium |
Mouse Genome Informatics
- Gene name
- Nlrx1
- Phenotype
- homeostasis/metabolism phenotype; growth/size/body region phenotype; immune system phenotype; hematopoietic system phenotype;
Gene ontology
- Biological process
- viral process;negative regulation of type I interferon production;negative regulation of interferon-beta production;negative regulation of interleukin-6 production;intracellular signal transduction;negative regulation of RIG-I signaling pathway;negative regulation of I-kappaB kinase/NF-kappaB signaling;innate immune response;negative regulation of innate immune response;negative regulation of inflammatory response
- Cellular component
- cytoplasm;mitochondrion;mitochondrial outer membrane;plasma membrane;cell junction
- Molecular function
- protein binding;ATP binding